# Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

> **NCT00075426** · PHASE2 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 30 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** arsenic trioxide

## Key facts

- **NCT ID:** NCT00075426
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075426, "Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00075426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*